FDA Updates Templates for Serology Test EUA Requests
The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data and provide new recommendations.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Compliance, Covid 19 |
The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data and provide new recommendations.
Read MorePosted by | May 4, 2020 | Calibrators, Clinical Chemistry, Controls, Quality Systems, Standards |
The set of definitive method reference materials contains seven routine chemistry components, covering 42 individual concentrations.
Read MorePosted by Steve Halasey | Apr 13, 2020 | Compliance, Computing Systems, Information Technology, Lab Management, Middleware & Software |
AI-driven software can help labs expertly navigate the prior authorization landscape.
Read MorePosted by | Apr 8, 2020 | Compliance, Infectious Diseases, Lab Management, Molecular Diagnostics |
If the agency’s proposed reclassification is finalized, devices of this type may go through the 510(k) pathway for clearance instead of the premarket approval (PMA) pathway.
Read MorePosted by Steve Halasey | Mar 31, 2020 | Compliance, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Lab Management |
The waiver will provide temporary relief from federal regulations requiring pathologists to render primary diagnoses onsite at healthcare facilities.
Read More